Concepedia

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study

Unknown author(s)

The Lancet Respiratory Medicine · 2022 · 111 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine · 2020 · 10.7K citations · Full text

, , +17

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

A. Danielle Iuliano, Katherine Roguski, Howard H. Chang et al. · The Lancet · 2017 · 3K citations · Full text

, , +14

Interval estimation for the difference between independent proportions: comparison of eleven methods

Robert G. Newcombe · Statistics in Medicine · 1998 · 1.8K citations

, , +16

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas, Frederick J. Angulo, John M. McLaughlin et al. · The Lancet · 2021 · 1.8K citations · Full text

, , +17

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Evan J. Anderson, Nadine Rouphael, Alicia T. Widge et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text

, , +17